Price$466.65-0.04 (-0.01%)
01:30 PM07:45 PM
News · 26 weeks91-29%
2025-10-262026-04-19
Mix4990d
- Insider27(55%)
- SEC Filings12(24%)
- Other5(10%)
- Earnings3(6%)
- Dividends1(2%)
- Analyst1(2%)
Latest news
25 items- SECThermo Fisher Scientific Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)
- PRThermo Fisher Scientific Reports First Quarter 2026 ResultsThermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 28, 2026. First Quarter Highlights First quarter revenue grew 6% to $11.01 billion. First quarter GAAP diluted earnings per share (EPS) grew 11% to $4.43. First quarter adjusted EPS grew 6% to $5.44. Delivered excellent performance in the first quarter, demonstrating the strength of our proven growth strategy, the power of our PPI Business System, and the continued active management of our company. Advanced our proven growth strategy, launching a range of high-impact, innovative new products during the quarter. This includ
- PRAI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost AdvantagesAUSTIN, Texas, April 09, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: As regulatory demands intensify and production environments become more complex, pharmaceutical manufacturers are shifting beyond traditional quality assurance systems toward a new operational model: integrating artificial intelligence directly into manufacturing workflows as a continuous compliance layer. Rather than depending on retrospective audits and manual checks, AI-driven technologies are now capable of monitoring, validating and optimizing production processes in real time to ensure alignment with evolving Good Manufacturing Practice (GMP) requirements. This transformation is becoming increasingly vis
- PRThermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PRECISE-SG100K Singapore to Advance Population-Scale ProteomicsThermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced a strategic collaboration with Precision Health Research, Singapore (PRECISE) to advance the PRECISE-SG100K study, one of the region's most ambitious and diverse population-scale biobank initiatives. The collaboration reflects growing investments from national population studies looking to harness proteomics to drive insight into real-time disease biology for application in earlier detection, prevention and personalized care. As biobanks become central to national health strategies over the next decade, the integration of multi-omic platforms and AI-driven analytics is critical. When applied to
- SECSEC Form DEFA14A filed by Thermo Fisher Scientific IncDEFA14A - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)
- SECSEC Form DEF 14A filed by Thermo Fisher Scientific IncDEF 14A - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)
- PRThermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 23, 2026Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2026 before the market opens on Thursday, April 23, 2026, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. The call will be webcast live on the "Investors" section of our website, www.thermofisher.com. You can access the conference call by dialing (833) 470-1428 within the U.S. or +1 (646) 844-6383 outside the U.S. The access code is 723173. The earnings press release and related information can also be found in that sec
- INSIDERSEC Form 4 filed by Sperling Scott M4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERSEC Form 4 filed by Keith R. Alexandra4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERSEC Form 4 filed by Lynch Karen S4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERSEC Form 4 filed by Johnson Jennifer M4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERSEC Form 4 filed by Weisler Dion J4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- ANALYSTDZ Bank initiated coverage on Thermo Fisher with a new price targetDZ Bank initiated coverage of Thermo Fisher with a rating of Buy and set a new price target of $610.00
- SECThermo Fisher Scientific Inc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)
- PRThermo Fisher Scientific Completes Acquisition of Clario Holdings, Inc.Further strengthens Thermo Fisher's position as the trusted partner to pharma and biotech customers, delivering important customer benefits Attractive return profile given high growth and strong margin profile of Clario, and meaningful synergies – reflecting the company's disciplined approach to capital deployment Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced the completion of its acquisition of Clario Holdings, Inc., a leading provider of endpoint data solutions for clinical trials, for $8.875 billion in cash, plus potential additional earnout and other payments, largely dependent on performance. With the transaction complete, the Clario
- INSIDERExecutive Vice President Shafer Michael D sold $802,536 worth of shares (1,607 units at $499.40), decreasing direct ownership by 7% to 20,950 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERNew insider Meyer James claimed ownership of 5,891 shares (SEC Form 3)3 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERChairman & CEO Casper Marc N exercised 4,000 shares at a strike of $309.63 and sold $2,059,261 worth of shares (4,000 units at $514.82) (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERChairman & CEO Casper Marc N sold $5,077,489 worth of shares (10,000 units at $507.75) and exercised 10,000 shares at a strike of $309.63 (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- SECSEC Form 144 filed by Thermo Fisher Scientific Inc144 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Subject)
- SECSEC Form 144 filed by Thermo Fisher Scientific Inc144 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Subject)
- INSIDERChairman & CEO Casper Marc N covered exercise/tax liability with 4,685 shares, decreasing direct ownership by 4% to 123,925 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERSr. VP and Chief HR Officer Britt Lisa P. covered exercise/tax liability with 348 shares, decreasing direct ownership by 2% to 14,784 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERVP & Chief Accounting Officer Holmes Joseph R. covered exercise/tax liability with 117 shares, decreasing direct ownership by 4% to 2,966 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERExecutive Vice President Lagarde Michel covered exercise/tax liability with 1,197 shares, decreasing direct ownership by 1% to 85,151 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)